19 results about "Boswellia" patented technology

The invention belongs to the technical field of application of natural extracts, and particularly discloses application of Boswellia amoena essential oil in prevention and treatment of aquatic diseases, in particular application of Boswellia amoena essential oil in inhibition of shewanella algal and vibrio alginolyticus. According to the application, various plant essential oils are tested, the bacteriostatic activity of the plant essential oils on two marine vibrios, i.e., shewanella alginate and vibrio alginolyticus, is researched by a filter paper method and a gradient dilution method, and GC-MS analysis is further performed on several essential oils; according to comprehensive analysis, the frankincense Aman has a remarkable effect on inhibiting shewanella and vibrio alginolyticus, and reference can be provided for application of the frankincense Aman essential oil to prevention and treatment of aquatic diseases.

Oral tablet comprising as active principle an association of dry extracts of turmeric, pomegranate and Boswellia, with colonic release, wherein said release is guaranteed by the presence of a combination of sodium alginate and hydroxypropyl methylcellulose in the relative matrix in which the aforementioned active ingredients are dispersed. This oral tablet, preferably in the form of a food supplement, is employed as co-adjuvant in the treatment and prevention of colonic disorders caused by suspected or confirmed alteration of the inflammatory situation and destabilization of the microbiota.

Pharmaceutical formulations and methods to increase the bioactivity and bioavailability of plant compound having hydrophobic phytochemicals which have poor bioavailability due to poor water solubility. Dispersions of extracts of Boswellia and / or Curcuma longa in sesame seed oil. Analgesic and anti-inflammatory composition having a) an extract of Boswellia, b) one or more of an extract of Curcuma longa, a curcuminoid composition and combinations thereof, and, c) a sesame seed oil. The analgesic and anti-inflammatory composition has particles having a particle size ranging from less than about 20 micrometers to about 1 micrometer. The analgesic and anti-inflammatory composition provides a total combined specific surface area provided by particles in the composition ranging from about 900 meter2 per kilogram to about 3000 meter2 per kilogram of the composition. Methods of preparing the compositions and methods of treating inflammation and musculoskeletal disorders are provided.

To provide a natural product-derived composition that allows for the easy intake of nutrients that can exhibit excellent functionality. [Solution] The composition comprises a collagen-containing extract derived from fish cartilage and a boswellic acid-containing extract derived from the Boswellia plant. The collagen-containing extract preferably contains type II collagen and type XI collagen, with a total mass ratio of their contents being 10:1 to 1:10, and a total content of 30% by mass or more. The boswellic acid-containing extract preferably contains 20% by mass or more of boswellic acid.

The invention belongs to the technical field of biological medicines, and particularly relates to a traditional Chinese medicine composition for treating orthopedic soft tissue injury and a preparation method thereof. The composition comprises the following raw materials in parts by weight: 4-6 parts of centella asiatica extract, 4-6 parts of salvia miltiorrhiza extract, 4-6 parts of pseudo-ginseng extract, 2-3.5 parts of eucommia ulmoides extract, 2-4 parts of liquorice extract, 4-7 parts of frankincense resin extract, 4-6.5 parts of turmeric extract and 3-4.5 parts of ligusticum wallichii extract. According to the invention, breakthrough is realized through prescription-drug delivery system-process triple synergy, and in prescription, the eight traditional Chinese medicine extracts are in multi-target synergy, and the whole process of anti-inflammation, analgesia and repair promotion is covered. On the delivery system, the hydrophilic component is included by cyclodextrin to be solubilized and stable, and the lipophilic component is efficiently transdermally loaded in the temperature-sensitive gel in the form of nanoemulsion to form a long-acting drug delivery bin on the skin. According to the process, microscopic uniformity and macroscopic stability of the system are ensured through precise low-temperature swelling, split-phase treatment and vacuum integration.

This invention discloses a strain of *Bosea vestrisii* and its application in promoting plant growth and improving salt tolerance. This strain is deposited at the China Center for Type Culture Collection (CCTCC) under accession number CCTCC M 2026307. *Bosea vestrisii* exhibits strong salt tolerance and possesses multiple growth-promoting functions, including secreting indoleacetic acid (IAA), synthesizing extracellular polysaccharides, and biological nitrogen fixation. Experiments show that applying this strain to wheat roots significantly increases plant height, root length, and biomass under salt stress, and enhances the activity of antioxidant enzymes (such as catalase, peroxidase, and superoxide dismutase) in the plant, effectively alleviating oxidative damage caused by salt stress. This invention provides a highly efficient and environmentally friendly microbial resource for improving saline-alkali soils, enhancing crop stress tolerance, and achieving sustainable agriculture.

Disclosed in the present invention is a synergistic phytomedical mind and body wellbeing formulation involving a botanical composition with a dual approach to inhibit Cyclooxygenase (COX) and Lipoxygenase (LOX) enzymes that enhances nervine function for therapeutic intervention encompassing phytoceutical compositions and methods for treating inflammatory conditions, neurological and gut microbiome disorders. The formulation integrates a selected blend of natural ingredients with main active ingredients, including Stabilized Flax Meal, Cynatine® FLX, Sunflower Lecithin, Boswellia Extract, Turmeric / Curcumin C-3 Reduct®, Egg Shell Membrane, Green Oat Extract-Neuravena®, Hyaluronic Acid, Manganese Chelate and AstaReal® Astaxanthin are carefully chosen for their documented efficacy in addressing various dimensions of chronic pain and inflammation, as well as promoting joint / tissue health, gut health and cognitive function. Through synergistic action, these ingredients work in tandem to provide holistic relief from chronic inflammation, thereby improving quality of life without reliance on harsh pharmaceutical interventions.

The invention relates to the technical field of tobacco flavors and fragrances, in particular to frankincense-style tobacco flavors and application of the frankincense-style tobacco flavors in cigarette perfuming. The tobacco essence comprises the following components in parts by mass: 0.1-25 parts of a main aroma component, wherein the main aroma component comprises a frankincense extract and frankincense essential oil; 2.01-37.2 parts of a head incense component, wherein the head incense component is prepared from acetic acid, ethyl butyrate, ethyl hexanoate, ethyl heptanoate, ethyl caprylate, ethyl caprate, gamma-heptanolactone, gamma-octanolactone, delta-octanolactone, gamma-nonanolactone, delta-decalactone, gamma-undecalactone, heliotropin, furfural, caprylic aldehyde, capric aldehyde, vanillin, ethyl vanillin, maltol and ethyl maltol; 2-20 parts of a modification component, wherein the modification component comprises a lactic acid propylene glycol reaction mixture; and 40-80 parts of a solvent. The tobacco essence perfume is applied to tobacco products, can endow frankincense fragrance, increase sweet fragrance, cover offensive odor and reduce irritation.

The present invention provides a synergistic composition comprising Boswellia- derived Frankincense oil and boswellic acid as well as methods for the synthesis of the same. Said synergistic composition comprising Frankincense oil and boswellic acid is prepared by subjecting Boswellia serrata resin gum to hydro-steam distillation process at a slightly elevated pressure, and for a short period of time, without using any organic solvents for extraction. Said synergistic composition is also prepared by combining Boswellic extract comprising at least 5 % by weight of Boswellic acid with Frankincense oil, with the combined product remaining as a clear oil, and offering the benefits of both Boswellic extract containing boswellic acid, and Frankincense oil. Said synergistic composition comprising Frankincense oil and boswellic acid is administered through topical, transdermal or oral route for the treatment of skin cancer, breast cancer, arthritis, and IBS.

The application discloses a medicine-moxibustion combined medicine composition for treating lung cancer cancer-induced fatigue and application thereof. The medicine-moxibustion combined medicine composition can effectively solve the problem of oral and navel moxibustion combined medicine for treating lung cancer cancer-induced fatigue. The medicine-moxibustion combined medicine composition comprises a first unit oral traditional Chinese medicine composition and a second unit navel moxibustion traditional Chinese medicine composition. The first unit oral traditional Chinese medicine composition is prepared from Chinese yam, radix codonopsis, poria cocos, rhizoma atractylodis macrocephalae, ganoderma lucidum, dried tangerine or orange peel, lablab bean, lotus seed, prepared licorice, amomum villosum, coix seed and platycodon grandiflorum, is soaked in water, is boiled with a strong fire, is boiled with a weak fire, is filtered, is concentrated under reduced pressure, is dried, is crushed, is uniformly prepared into soft material by adding an auxiliary material and using ethanol as a wetting agent, is sieved and granulated, is dried, is whole-granulated, and is packed, and the second unit navel moxibustion traditional Chinese medicine composition is prepared from astragalus root, rhizoma atractylodis macrocephalae, wind-preventing herb, galangal, dried ginger, costus root, dried tangerine or orange peel, agarwood, frankincense and boswellia, is uniformly prepared by crushing and mixing, is rich in raw materials, is scientific and reasonable, is easy to produce and prepare, is convenient to use, is safe in medicine use, is good in curative effect, and has actual clinical application value.

The invention refers to the use resin extracts of tree species, related to Boswellia carterii, Boswellia negletta, Commiphora holziana, in treating chronic inflammation conditions, potentially leading to cancer, or autoimmune diseases like Alzheimer, Crohn's syndrome, psoriasis, multiple sclerosis, etc., and in relieving pain. A key aspect of our invention is the selection of the resin extracts or their components, able to modulate protein kinases activity, including PKC isoforms activity. The invention also relates to a method for producing extracts with a high concentration of bioactive compounds.

The present invention provides compositions comprising extracts from specific plant genera or alternatives thereof, including Lithospermum and Oryza or alternatives thereof, along with optional extracts from Scutellaria and Boswellia. The compositions thus include shikonin, anthocyanins, and other bioactive compounds such as flavonoids and boswellic acids. Additional ingredients like ivermectin, metformin, and curcumin may be incorporated. The compositions are designed as multi-targeted therapeutic agents, combining viral protease inhibitors, endogenous host protease inhibitors, anti-inflammatory agents, and anti-senescence agents. These compositions are intended for treating various medical conditions, including respiratory diseases, viral infections, inflammatory conditions, immune-related disorders, liver conditions, and neurological conditions. The invention describes methods of treatment and use in manufacturing medicaments for these conditions.

Present invention pertains to a plant-based formulation for fast pain relief and method of preparation of said pain relief formulation. Plant-based formulation is made from solid Turmeric extract and solid Boswellia extract loaded into an oil, with a Hydrophilic-lipophilic balance value ranging from 10 to 19. Administering said analgesic and anti-inflammatory formulation hastens the process of relief to a subject experiencing acute musculoskeletal pain.

A therapeutic herbal composition for the treatment and management of psoriasis, skin inflammations and related conditions, the composition comprising the following: an extract of Tinospora cordifolia in an amount ranging from 5 to 20 percent by weight of the total composition; an extract of Smilax china Linn in an amount of 2 to 15 percent by weight of the total composition; a gum resin of Boswellia dentate Roxb in an amount in the range of 5 to 25 percent by weight of the total composition; a common castor oil in an amount of 2 to 12 percent by weight of the total composition; and one or more pharmaceutically acceptable carriers, excipients or stabilizers.

The present application relates to a kind of plant active ingredient extraction method, specifically to a kind of industrialized continuous preparation method of frankincense extract.The technical problem that the preparation method of existing frankincense extract is solved, using alkaline solvent, AKBA component is easily degraded, leading to the technical problem of the loss of the best active ingredient of frankincense extract.The method of the present application comprises the following steps: 1) the raw material of frankincense is extracted by methanol to obtain residue A and filtrate A;After the concentration of filtrate A, add anion polyacrylamide and filter, the filtrate is adsorbed and eluted by macroporous adsorption resin to obtain frankincense flavone;Residue A is extracted by alcohol organic solvent to obtain filtrate B and residue B;Residue B is extracted by water, concentrated, dried to obtain frankincense polysaccharide;2) filtrate B is first concentrated to alcohol degree 65%-75% and then adsorbed by adsorbent, and the supernatant is collected by filtration;The supernatant is concentrated to alcohol degree 10%-30%, and the first precipitate is obtained by filtration;3) add organic solvent C, stir and rinse, collect the second precipitate by filtration, and dry to obtain frankincense acid extract.

Presently described are compositions comprising 55% w / w enriched Boswellia serrata extract containing 40% w / w total boswellic acids and 45% w / w enriched Apium graveolens L. seed extract containing 15% w / w celery bioactive (seselin and bergeptan) as quantified by HPLC, optionally along with pharmaceutically or nutraceutically acceptable excipients. The composition exhibits a synergistic effect while reducing cartilage degenerative biomarkers and increasing cartilage regenerative biomarkers when used for the treatment of osteoarthritis. The administration of the said composition also results in the reduction of pain, inflammation, and stiffness and an increase in the gap between knee joints of patients suffering from knee osteoarthritis. The methods of enrichment of extracts, preparation of said composition and treatment of subjects suffering from cartilage degeneration and osteoarthritis are described.

It relates to an oral composition comprising Epilobium parviflorum extract, Nigella sativa extract, and Boswellia serrata extract in specific amounts and ratios. It also relates to the oral composition for use in the treatment of hair loss. The present invention also relates to the use of the oral composition for improving brightness, hydration, elasticity, firmness, and / or hair shine; or for improving brightness, hydration, elasticity, and firmness of the skin.